Home › Funds › Delaware/Macquarie › Nomura Growth and Income Fund
Fund family: Delaware/Macquarie · Filed by DELAWARE GROUP EQUITY FUNDS IV (CIK 778108) · SEC series S000065929
Share classes and tickers: FGINX (C000212968), FGIPX (C000212967), FGIQX (C000212969)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 667 with, 58 against, 16 abstentions (not counted as with management); 1 split votes are in neither count. Shareholder proposals: 25 FOR, 33 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Delaware/Macquarie’s manager page (15,554 ballot items across 17 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Delaware/Macquarie | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 93.0% | 668 | 92.2% | 13,591 |
| Backed environmental and social shareholder proposals at US companies | n/a | 32 | 24.8% | 266 |
Each ballot item this fund voted is set against the votes of the other Delaware/Macquarie funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Delaware/Macquarie funds on 1 item (0.2% of the 423 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Delaware/Macquarie funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Merck & Co., Inc. | 2026-05-26 | Election of Directors: Patricia F. Russo | For | AGAINST — 2 of 3 Delaware/Macquarie funds | For | Elected, 88.3% support |
Download all 1 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 741 such votes could be given a sector.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 181 | 7 | 3.9% |
| Health Care | 123 | 10 | 8.1% |
| Consumer Discretionary | 115 | 6 | 5.2% |
| Technology | 90 | 21 | 23.3% |
| Industrials | 84 | 4 | 4.8% |
| Telecommunications | 59 | 7 | 11.9% |
| Energy | 48 | 2 | 4.2% |
| Consumer Staples | 22 | 1 | 4.5% |
| Basic Materials | 14 | 0 | 0.0% |
| Real Estate | 5 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 530 | 0 |
| Audit-related | 54 | 0 |
| Say-on-Pay | 54 | 0 |
| Corporate Governance | 32 | 20 |
| Compensation | 25 | 1 |
| Environment or Climate | 16 | 16 |
| Other Social Issues | 14 | 13 |
| Capital Structure | 6 | 0 |
| Shareholder Rights and Defenses | 6 | 5 |
| Extraordinary Transactions | 4 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Micron Technology, Inc. | January 15, 2026 | $190M | 12 | 1 |
| Exxon Mobil Corporation | May 27, 2026 | $106M | 17 | 2 |
| Cisco Systems, Inc. | December 16, 2025 | $97M | 13 | 1 |
| Gilead Sciences, Inc. | April 30, 2026 | $79M | 15 | 3 |
| McKesson Corporation | July 30, 2025 | $77M | 14 | 0 |
| Citigroup Inc. | May 20, 2026 | $73M | 16 | 0 |
| Philip Morris International Inc. | May 6, 2026 | $69M | 13 | 1 |
| CVS Health Corporation | May 14, 2026 | $67M | 17 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| January 15, 2026 | Micron Technology, Inc. | SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Independent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Proposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposal | For | Against |
| December 16, 2025 | Cisco Systems, Inc. | Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 6, 2026 | Philip Morris International Inc. | Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposal | Against | For |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | For | Against |
| May 5, 2026 | Bristol-Myers Squibb Company | Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposal | Against | For |
| May 14, 2026 | AT&T Inc. | Shareholder Right to Act by Written Consent Shareholder proposal | For | Against |
| May 14, 2026 | AT&T Inc. | EEO-1 Report Disclosure Policy Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
744 ballot items at 56 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Nomura Growth and Income Fund (FGINX) voted at 56 shareholder meetings of 55 companies, on 744 ballot items in all. Where management made a recommendation, the fund followed it on 90.0% of the items and voted against it 58 times. Its most frequent area of disagreement was corporate governance (20 of its votes against management). It voted FOR 43.1% of the 58 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Delaware/Macquarie's funds as a whole (93.0% against 92.2%). It voted differently from most Delaware/Macquarie funds on 1 item.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Delaware/Macquarie’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.